Target Name: DUSP5
NCBI ID: G1847
Review Report on DUSP5 Target / Biomarker Content of Review Report on DUSP5 Target / Biomarker
DUSP5
Other Name(s): serine/threonine specific protein phosphatase | Serine/threonine specific protein phosphatase | VH1-like phosphatase 3 | dual specificity protein phosphatase hVH3 | DUSP | DUS5_HUMAN | VH3 | Dual specificity phosphatase 5 | Dual specificity protein phosphatase hVH3 | Dual specificity protein phosphatase 5 | HVH3 | dual specificity phosphatase 5

DUSP5: A Drug Target / Disease Biomarker

DUSP5, short forDiscovery Using Single-Particle Analysis for Proteomics, is a technology that has the potential to revolutionize drug discovery by providing a highly sensitive and efficient method for the analysis of biomarkers. By utilizing single-particle analysis, DUSP5 can identify even the slightest changes in protein levels, which can be difficult to detect using traditional methods.

DUSP5 technology works by using a variety of techniques to analyze the physical characteristics of each protein molecule, such as its size, shape, and chemical makeup. By analyzing these characteristics, DUSP5 can determine the presence or absence of a particular protein molecule, as well as quantify its levels in the sample.

One of the key benefits of DUSP5 is its ability to detect changes in protein levels that are difficult to detect using traditional methods. For example, DUSP5 has been used to detect changes in the levels of proteins involved in cancer, neurodegenerative diseases, and other conditions. In addition, DUSP5 has been shown to be highly sensitive, with the minimum detectable concentration of a protein molecule as low as 5 copies per million.

In addition to its potential use as a drug target or biomarker, DUSP5 has also has potential applications in a variety of other fields. For example, it can be used to monitor the effectiveness of cancer treatments by measuring the levels of cancer-related proteins in the body. In addition, DUSP5 can be used to identify potential new targets for drugs by analyzing the proteins involved in a disease and identifying those that are over-expressed or under-expressed in the disease.

Overall, DUSP5 is a powerful tool for the analysis of proteins and their associated biomarkers. With its ability to detect changes in protein levels that are difficult to detect using traditional methods, DUSP5 has the potential to revolutionize drug discovery and lead to the development of new treatments for a variety of diseases.

Protein Name: Dual Specificity Phosphatase 5

Functions: Dual specificity protein phosphatase; active with phosphotyrosine, phosphoserine and phosphothreonine residues. The highest relative activity is toward ERK1

The "DUSP5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUSP5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DUSP5P1 | DUSP6 | DUSP7 | DUSP8 | DUSP8P5 | DUSP9 | DUT | DUTP6 | DUX1 | DUX3 | DUX4 | DUX4L1 | DUX4L13 | DUX4L16 | DUX4L18 | DUX4L19 | DUX4L2 | DUX4L20 | DUX4L23 | DUX4L3 | DUX4L37 | DUX4L4 | DUX4L5 | DUX4L6 | DUX4L7 | DUX4L8 | DUX4L9 | DUXA | DUXAP10 | DUXAP3 | DUXAP8 | DUXAP9 | DVL1 | DVL2 | DVL3 | DXO | DYDC1 | DYDC2 | DYM | Dynactin | DYNAP | DYNC1H1 | DYNC1I1 | DYNC1I2 | DYNC1LI1 | DYNC1LI2 | DYNC2H1 | DYNC2I1 | DYNC2I2 | DYNC2LI1 | DYNLL1 | DYNLL2 | DYNLRB1 | DYNLRB2 | DYNLRB2-AS1 | DYNLT1 | DYNLT2 | DYNLT2B | DYNLT3 | DYNLT4 | DYNLT5 | DYRK1A | DYRK1B | DYRK2 | DYRK3 | DYRK4 | DYSF | Dystrophin-Associated Glycoprotein Complex | DYTN | DZANK1 | DZIP1 | DZIP1L | DZIP3 | E2F Transcription Factor | E2F-6 complex | E2F1 | E2F2 | E2F3 | E2F4 | E2F5 | E2F6 | E2F6P4 | E2F7 | E2F8 | E3 ubiquitin-protein ligase | E4F1 | EAF1 | EAF2 | EAPP | Early growth response | EARS2 | EBAG9 | EBF1 | EBF2 | EBF3 | EBF4 | EBI3 | EBLN1 | EBLN2 | EBLN3P